Congress Archives

Politics John Wilkerson

The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

Politics Jonathan Wosen

Liquid-biopsy firm Grail is spending more than ever lobbying Congress

Politics Sarah Owermohle

Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates

First Opinion Paul Hastings

Biopharma leaders helped save democracy. Now what?

Politics Rachel Cohrs

3 drug pricing issues to watch in 2023

Business Bob Herman and Tara Bannow

3 trends to watch in hospitals and health insurance in 2023

The Aduhelm Files Rachel Cohrs, Adam Feuerstein and Damian Garde

FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation

The Aduhelm Files Rachel Cohrs

‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol

The Aduhelm Files Damian Garde and Adam Feuerstein

Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds

D.C. Diagnosis Rachel Cohrs

After nine months, an update on NIH’s long Covid research

Politics Sarah Owermohle

Amid dire maternal mortality rates, Congress falls short on Medicaid postpartum care

Politics Rachel Cohrs and Sarah Owermohle

Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness

Politics Rachel Cohrs and Sarah Owermohle

AbbVie exits major pharmaceutical industry lobbying groups

Health Tara Bannow

Nine in 10 health care companies with financial stress are owned by private equity

Politics Sarah Owermohle

New Biden changes to Obamacare coverage for generics splits the industry

Politics Bob Herman

Medicare chief: ‘Door is really open’ on coverage for new Alzheimer’s drug

Politics Rachel Cohrs and Sarah Owermohle

Congress has a chance to close the FDA’s Theranos loophole

Politics Sarah Owermohle

ARPA-H’s new director wants to go on a hiring spree

Politics John Wilkerson

FDA chief calls agency’s food program ‘under-supported, under-resourced’

Health Lev Facher

Congress has its sights set too low on addiction, advocates charge

First Opinion Scott Gottlieb and Mark B. McClellan

Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics

First Opinion Arthur L. Caplan and Kenneth I. Moch

Breakthrough Therapies Act: Good idea, wrong solution

First Opinion Bill Frist and Dariush Mozaffarian

Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans

Health Jeff Allen and Lisa Lacasse

Better lab test standards can ensure precision medicine is truly precise

Politics Bob Herman

Congress

Most Read

Congressional Medicare advisers warn of higher drug prices, despite new price negotiation

Biden Covid adviser David Kessler to exit as pandemic response winds down

HHS will seek more input on its new Medicare drug price negotiations

Will America’s public health reckoning ever come?

HHS will decide how to resolve $1 billion in payments for 340B hospitals

Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee

Rep. Jason Smith and the other Republicans leading health policy in the House

Officials in Nebraska, South Dakota, Oklahoma begin to probe prisons’ hepatitis C treatment efforts

All Coverage

The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

Liquid-biopsy firm Grail is spending more than ever lobbying Congress

Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates

Biopharma leaders helped save democracy. Now what?

3 drug pricing issues to watch in 2023

3 trends to watch in hospitals and health insurance in 2023

FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation

‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol

Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds

After nine months, an update on NIH’s long Covid research

Amid dire maternal mortality rates, Congress falls short on Medicaid postpartum care

Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness

AbbVie exits major pharmaceutical industry lobbying groups

Nine in 10 health care companies with financial stress are owned by private equity

New Biden changes to Obamacare coverage for generics splits the industry

Medicare chief: ‘Door is really open’ on coverage for new Alzheimer’s drug

Congress has a chance to close the FDA’s Theranos loophole

ARPA-H’s new director wants to go on a hiring spree

FDA chief calls agency’s food program ‘under-supported, under-resourced’

Congress has its sights set too low on addiction, advocates charge

Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics

Breakthrough Therapies Act: Good idea, wrong solution

Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans

Better lab test standards can ensure precision medicine is truly precise

Patient groups push federal government to enforce health care price estimates

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day